Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

Wermke, M., Araujo, D. M., Chatterjee, M., Tsimberidou, A. M., Holderried, T. A. W., Jazaeri, A. A., Reshef, R., Bokemeyer, C., Alsdorf, W., Wetzko, K., Brossart, P., Aslan, K., Backert, L., Bunk, S., Fritsche, J., Gulde, S., Hengler, S., Hilf, N., Hossain, M. B., … Britten, C. M. (2025). Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial. Nature Medicine. https://doi.org/10.1038/s41591-025-03650-6
Authors:
Martin Wermke
Dejka M Araujo
Manik Chatterjee
Apostolia M Tsimberidou
Tobias A W Holderried
Amir A Jazaeri
Ran Reshef
Carsten Bokemeyer
Winfried Alsdorf
Katrin Wetzko
Peter Brossart
Katrin Aslan
Linus Backert
Sebastian Bunk
Jens Fritsche
Swapna Gulde
Silvana Hengler
Norbert Hilf
Mohammad B Hossain
Jens Hukelmann
Mamta Kalra
Delfi Krishna
M Alper Kursunel
Dominik Maurer
Andrea Mayer-Mokler
Regina Mendrzyk
Ali Mohamed
Karine Pozo
Arun Satelli
Marilena Letizia
Heiko Schuster
Oliver Schoor
Claudia Wagner
Hans-Georg Rammensee
Carsten Reinhardt
Harpreet Singh-Jasuja
Steffen Walter
Toni Weinschenk
Jason J Luke
Cedrik M Britten
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1038/s41591-025-03650-6
PMID:
40205198
DOI:
10.1038/s41591-025-03650-6
Journal:
Nature Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: